Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
Lietz
K
K
Department of Surgery, Columbia Presbyterian Medical Center, Columbia University, 630W 168th Street, New York, NY 10032, USA.
John
R
R
Schuster
M
M
Ankersmit
J
J
Burke
E
E
Suciu-Foca
N
N
Edwards
N
N
Mancini
D
D
Itescu
S
S
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine